查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1474864

表觀遺傳學市場規模、佔有率、趨勢分析報告：按產品、按技術、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application (Oncology), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

表觀遺傳學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球表觀遺傳學市場規模將達到391.5億美元，2024年至2030年複合年成長率為15.3%。

該市場的推動因素包括表觀遺傳學研究和開發的資金籌措、投資和法規核准的增加、表觀遺傳酶在藥物發現和開發中的使用的擴大以及基因組序列測定成本的降低。隨著表觀遺傳學已證明其在腫瘤學之外的有益應用，預計將實現商業性擴張。對在分子層面上了解表觀遺傳變化和藥物治療進步的需求不斷成長，可能會推動這些組織支持研究和開發計畫。

此外，流行病學和基因組學研究計劃 (EGRP) 等舉措獎勵了旨在更好地了解腫瘤發展和結果的研究工作。推動市場成長的一些組織包括國際人類表觀基因聯盟(IHEC)、美國癌症研究所 (NCI) 和美國國立衛生研究院 (NIH)。這些組織資助和支持包括表觀遺傳學領域的產品開發和研究與開發在內的舉措。例如，美國國立衛生研究院透過通用基金表觀基因計劃，在全球範圍內積極推動尖端表觀遺傳學研究。

表觀遺傳學市場報告亮點

  • 從產品來看，試劑細分市場佔據主導地位，2023年佔全球收益的33.45%。此細分市場的主要佔有率歸因於表觀遺傳學研究中試劑的高使用率。
  • 從技術來看，DNA甲基化細分市場佔據主導地位，2023年銷售佔有率為45.36%。表觀遺傳學對DNA甲基化的需求源自於其在調節基因表現中的關鍵角色。
  • 從應用來看，腫瘤學佔據市場主導地位，2023 年銷售佔有率為 69.06%。腫瘤對錶觀遺傳學的需求源自於表觀遺傳學變化與癌症發展之間的複雜關係。
  • 北美市場佔據主導地位，2023 年市佔率為 38.19%。由於公眾意識的提高、醫療設施的改善以及大量的研發投資，該地區正在經歷成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章表觀遺傳學市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 市場機會分析
  • 表觀遺傳學市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章表觀遺傳學市場：產品評估與趨勢分析

  • 細分儀表板
  • 全球表觀遺傳學市場產品趨勢分析
  • 2018-2030年全球表觀遺傳學市場規模與趨勢分析（按產品）
  • 試劑
  • 套件
  • 裝置
  • 酵素
  • 服務

第5章表觀遺傳學市場：技術評估與趨勢分析

  • 細分儀表板
  • 全球表觀遺傳學市場技術趨勢分析
  • 2018-2030 年全球表觀遺傳學市場規模與趨勢分析（按技術）
  • DNA甲基化
  • 組蛋白甲基化
  • 組蛋白乙醯化
  • 大非編碼RNA
  • 微型RNA修飾
  • 染色質結構

第6章表觀遺傳學市場：應用估算與趨勢分析

  • 細分儀表板
  • 全球表觀遺傳學市場應用趨勢分析
  • 2018-2030 年全球表觀遺傳學市場規模與趨勢分析（按應用）
  • 瘤
  • 非腫瘤

第7章表觀遺傳學市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球表觀遺傳學市場最終用途趨勢分析
  • 2018-2030 年全球表觀遺傳學市場規模與趨勢分析（依最終用途）
  • 學術研究
  • 臨床研究
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第8章表觀遺傳學市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模與預測/趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Eisai Co., Ltd.
    • Novartis AG
    • ELEMENT BIOSCIENCES.
    • Dovetail Genomics.
    • Illumina, Inc.
    • Promega Corporation
    • Abcam plc
Product Code: 978-1-68038-583-0

Epigenetics Market Growth & Trends:

The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.

Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.

Epigenetics Market Report Highlights:

  • By product, the reagents segment dominated the industry, accounting for 33.45% of the global revenue in 2023. The large share of this segment can be attributed to the high usage of reagents in epigenetic research studies.
  • By technology, the DNA methylation segment dominated the market with a revenue share of 45.36% in 2023. DNA methylation's demand in epigenetics stems from its pivotal role in gene expression regulation.
  • By application, the oncology segment dominated the market with a revenue share of 69.06% in 2023. Oncology's demand for epigenetics arises from the intricate relationship between epigenetic alterations and cancer development.
  • North America dominated the market and accounted for a 38.19% share in 2023. The region experiences growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective - 1
    • 1.10.2. Objective - 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Epigenetics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Rising geriatric patient population
      • 3.2.1.3. Increasing government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of standardization in epigenetics-based diagnostics
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improving healthcare infrastructure in developing economies
  • 3.3. Epigenetics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Epigenetics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Epigenetics Market Product Movement Analysis
  • 4.3. Global Epigenetics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Kits
    • 4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. ChIP sequencing Kit
      • 4.5.2.1. ChIP sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Whole Genomic Amplification Kit
      • 4.5.3.1. Whole genomic amplification kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Bisulfite Conversion Kit
      • 4.5.4.1. Bisulfite conversion kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. RNA sequencing Kit
      • 4.5.5.1. RNA sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Instruments
    • 4.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Services
    • 4.8.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Epigenetics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Epigenetics Market Technology Movement Analysis
  • 5.3. Global Epigenetics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. DNA Methylation
    • 5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Histone Methylation
    • 5.5.1. Histone methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Histone Acetylation
    • 5.6.1. Histone Acetylation Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Large non-coding RNA
    • 5.7.1. Large non-coding RNA market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MicroRNA modification
    • 5.8.1. MicroRNA modification market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Chromatin structures
    • 5.9.1. Chromatin structures market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Epigenetics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Epigenetics Market Application Movement Analysis
  • 6.3. Global Epigenetics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Solid tumors
      • 6.4.2.1. Solid tumors market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Liquid tumors
      • 6.4.3.1. Liquid tumors market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Non-oncology
    • 6.5.1. Non-oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Inflammatory diseases
      • 6.5.2.1. Inflammatory diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Metabolic diseases
      • 6.5.3.1. Metabolic diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Infectious diseases
      • 6.5.4.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Cardiovascular diseases
      • 6.5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Others
      • 6.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Epigenetics Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Epigenetics Market End-use Movement Analysis
  • 7.3. Global Epigenetics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 7.4. Academic Research
    • 7.4.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Research
    • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Hospitals & Clinics
    • 7.6.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Pharmaceutical & Biotechnology Companies
    • 7.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Other Users
    • 7.8.1. Other users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Epigenetics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Target disease prevalence
      • 8.4.2.4. Competitive scenario
      • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Target disease prevalence
      • 8.4.3.4. Competitive scenario
      • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Target disease prevalence
      • 8.5.2.4. Competitive scenario
      • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Target disease prevalence
      • 8.5.3.4. Competitive scenario
      • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Target disease prevalence
      • 8.5.4.4. Competitive scenario
      • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Target disease prevalence
      • 8.5.5.4. Competitive scenario
      • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Target disease prevalence
      • 8.5.6.4. Competitive scenario
      • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Target disease prevalence
      • 8.5.7.4. Competitive scenario
      • 8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Target disease prevalence
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Competitive scenario
      • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Target disease prevalence
      • 8.5.9.4. Competitive scenario
      • 8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Target disease prevalence
      • 8.6.2.4. Competitive scenario
      • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Target disease prevalence
      • 8.6.3.4. Competitive scenario
      • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Target disease prevalence
      • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Target disease prevalence
      • 8.6.5.4. Competitive scenario
      • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Target disease prevalence
      • 8.6.6.4. Competitive scenario
      • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Target disease prevalence
      • 8.6.7.3. Regulatory framework
      • 8.6.7.4. Competitive scenario
      • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Target disease prevalence
      • 8.7.2.4. Competitive scenario
      • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Target disease prevalence
      • 8.7.3.4. Competitive scenario
      • 8.7.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Target disease prevalence
      • 8.7.4.4. Competitive scenario
      • 8.7.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Target disease prevalence
      • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Target disease prevalence
      • 8.8.3.4. Competitive scenario
      • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Target disease prevalence
      • 8.8.4.4. Competitive scenario
      • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Target disease prevalence
      • 8.8.5.4. Competitive scenario
      • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Thermo Fisher Scientific Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Eisai Co., Ltd.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Novartis AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. ELEMENT BIOSCIENCES.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Dovetail Genomics.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Illumina, Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Promega Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Abcam plc
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global epigenetics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Europe epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Germany epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 34 France epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 France epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 36 France epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Italy epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Spain epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Norway epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 China epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 63 China epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 64 China epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 China epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 71 India epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 India epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 73 India epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Thailand epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Latin America epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Brazil epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Mexico epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait epigenetics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Epigenetics market: Market outlook
  • Fig. 5 Epigenetics market: Segment outlook
  • Fig. 6 Epigenetics market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Epigenetics market driver impact
  • Fig. 9 Epigenetics market restraint impact
  • Fig. 10 Epigenetics market: Product outlook and key takeaways
  • Fig. 11 Epigenetics market: Product movement analysis
  • Fig. 12 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 ChIP sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Whole genomic amplification kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Bisulfite conversion kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 RNA sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Epigenetics market: Technology outlook and key takeaways
  • Fig. 23 Epigenetics market: Technology movement analysis
  • Fig. 24 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Histone methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Histone acetylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Large non-coding RNA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 MicroRNA modification market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chromatin structures market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Epigenetics market: Application outlook and key takeaways
  • Fig. 31 Epigenetics market: Application movement analysis
  • Fig. 32 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Solid tumors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Liquid tumors market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 35 Non-oncology market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 36 Inflammatory diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Metabolic diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 38 Infectious diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Cardiovascular diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Epigenetics market: End-use outlook and key takeaways
  • Fig. 42 Epigenetics market: End-use movement analysis
  • Fig. 43 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Clinical research market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 45 Hospitals & Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 47 Other users market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Global epigenetics market: Regional outlook and key takeaways
  • Fig. 49 Global epigenetics market: Regional movement analysis
  • Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)